All Stories

  1. Towards an open science publishing platform
  2. Early adopters of ORCID functionality enabling recognition of peer review: Two brief case studies
  3. Data exchange standards to support and acknowledge peer-review activity
  4. Altmetrics as a means of assessing scholarly output
  5. Guidelines on Recommending Data Repositories as Partners in Publishing Research Data
  6. Cross-Linking Between Journal Publications and Data Repositories: A Selection of Examples
  7. Processes and Procedures for Data Publication: A Case Study in the Geosciences
  8. Data-set visibility: Cite links to data in reference lists
  9. F1000 and data publishing
  10. Capturing lost research
  11. Capturing lost research
  12. Sir Richard Sykes contemplates the future of the pharma industry
  13. Sir Chris Evans divulges his experiences as an entrepreneur
  14. Editorial: top-ten start-up companies of 2001
  15. William Pardridge discusses the lack of BBB research
  16. James Gimzewski discusses the potential of nanobiotechnology
  17. Biofinance: what does the future hold?
  18. Steven Holtzman discusses partnering
  19. 20 years on: Donald Francis discusses advances in the fight against HIV
  20. Crispin Kirkman discusses the European biotech industry
  21. Reversing the paradigm for HT protein identification and validation
  22. Recursive deconvolution for real-time lead identification
  23. HTS personal perspectives: big pharma. Interview with Steve Young
  24. HTS personal perspectives: big pharma. Interview with Martin Valler
  25. HTS personal perspectives: big pharma. Interview with Manfred Auer
  26. HTS personal perspectives: big pharma. Interview with John Major
  27. Intelligent inhalers for systemic administration?
  28. Alastair Devlin discusses the concept of virtual pharma companies
  29. Dendritic vaccine promising for gliomas
  30. Biocomputing: impact of the genomic revolution
  31. Initial analyses of the human genome: does it reveal anything new?
  32. Novel topical and oral treatment for dermatitis and psoriasis
  33. New hope for fungal vaccines?
  34. What the industry says
  35. David Bentley discusses life after the Human Genome Project
  36. Craig Venter discusses life after the Human Genome Project
  37. Key strategies in functional genomics for drug discovery
  38. A new target for HIV-1 entry inhibition?
  39. Current approaches to multiple parallel synthesis
  40. Enhancing information sharing
  41. Rediscovering natural product biodiversity
  42. Digitalizing document production
  43. Endothelium-dependent Relaxation in Response to Ethanol in the Porcine Isolated Pulmonary Artery